🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Personalized Discovery Process is the only program offering patients tr...
Status
Terminated
Location
Icahn School of Medicine at Mount Sinai
Start Date
2015-01
Trial ID
NCT02363647
Treatments Being Tested
The purpose of this study is to examine the effects of an exercise program ...
Status
Unknown
Location
Multiple Locations
Start Date
2022-12-01
Trial ID
NCT05641571
Treatments Being Tested
This prospective cohort study aims to identify immune-related predictive fa...
Status
Active Not Recruiting
Location
Institute of Oncology Ljubljana
Start Date
2017-03-01
Trial ID
NCT07407244
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
The purpose of this study is to characterize the effects of 85 days treatme...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05-20
Trial ID
NCT02410499
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of venetocl...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2023-03-01
Trial ID
NCT06068621
The purpose of this study is to assess the efficacy and safety of the combi...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Start Date
2019-05-02
Trial ID
NCT03834506
Treatments Being Tested
This is a double-blind, randomized, placebo-controlled, parallel study. The...
Status
Unknown
Location
Chung-Ho Memorial Hospital, Kaohsiung Medical University:
Start Date
2018-11-09
Trial ID
NCT04342949
Treatments Being Tested
This is a single-center, prospective, single-arm, open-label phase II study...
Status
Completed
Location
Asan Medical Center
Start Date
2012-09
Trial ID
NCT01719549
Treatments Being Tested
The purpose of this study is to assess if adding revumenib to standard chem...
Status
Recruiting
Location
Clinical Trial Site
Start Date
2025-11-25
Trial ID
NCT07211958
Treatments Being Tested